Labiotech.eu

Best in Biotech 17 Oct 2023

Singapore’s biotech scene: six companies leading the way

Singapore set out to become a global biotech hub back in 2000, and, although still awaiting its big success story in the industry, it is currently a leading hub in…

October 17, 2023 - 8 minutesmins - By Willow Shah-Neville

Can we overcome the challenges of bispecific antibody production?

Thanks to their unique features, bispecific antibodies are the fastest-evolving class of biotherapeutics. However, the enormous clinical potential of their unconventional design is accompanied by equally large challenges. How can…

October 17, 2023 - 6 minutesmins - By Ute Boronowsky

In Depth 16 Oct 2023

Blockchain-based biotech: is this a viable financing method?

At a time when biotechs are scrambling to raise funds, a new way for startups to secure investments is emerging: leveraging cryptocurrency. The motive behind decentralized financing seems pretty ambitious…

October 16, 2023 - 10 minutesmins - By Roohi Mariam Peter

In Depth 13 Oct 2023

How close are we to a cure for metastatic breast cancer?

Currently considered an incurable disease, there is a lot of work being done around developing better treatment options for metastatic breast cancer, and, ultimately, a cure. Numerous promising candidates are…

October 13, 2023 - 8 minutesmins - By Willow Shah-Neville

Podcast 13 Oct 2023

Beyond Biotech podcast 67 – natural killer cells

This week, we speak to Artiva Biotherapeutics’ CEO, Fred Aslan, M.D. The company has demonstrated the potential for efficacy and safety with natural killer (NK) cells in two cancer clinical…

October 13, 2023 - 2 minutesmins - By Jim Cornall

In Depth 12 Oct 2023

Can immunometabolism-based therapies transform the way cancers and autoimmune diseases are treated?

The immune system protects our bodies from foreign invaders, but sometimes, when it malfunctions, it can result in life-threatening autoimmune disorders. But what if the immune system could be regulated…

October 12, 2023 - 9 minutesmins - By Roohi Mariam Peter

In Depth 11 Oct 2023

Project NextGen: The U.S. government’s $5 billion initiative to stay one step ahead of COVID-19

When SARS-CoV-2 spread out of Wuhan, China, to the rest of the world, it became only the fifth pandemic to be documented since the 1918 flu pandemic. As the entire…

October 11, 2023 - 6 minutesmins - By Willow Shah-Neville

Best in Biotech 10 Oct 2023

Bridging Science and Art: Five bioartists you should know about

Bioartists bridge art, born out of creativity and abstract thoughts, and science, which is rooted in facts, laws and logic, as a means of self-expression. The term bioart was coined…

October 10, 2023 - 10 minutesmins - By Roohi Mariam Peter

Drugging ‘undruggable’ targets: Are high-throughput proximity assays the answer?

Drug screening follows the funnel principle – the higher the number and diversity of compounds assayed, the better the chances to identify meaningful hits that turn into promising clinical candidates.…

October 10, 2023 - 5 minutesmins - By Ute Boronowsky

In Depth 9 Oct 2023

The biggest private biotech investments in September 2023

The companies Generate Biomedicines, Apollo Therapeutics and Nimbus Therapeutics bagged the biggest biotech investments in September 2023. Around the world, drug discovery and oncology players attracted the biggest funding rounds.…

October 9, 2023 - 3 minutesmins - By Willow Shah-Neville

In Depth 6 Oct 2023

Will the U.S. Cancer Moonshot program land its target to halve cancer death rates?

It was predicted that more than 600,000 people would die from cancer last year in the U.S., according to the American Cancer Society. But what if those figures could be…

October 6, 2023 - 10 minutesmins - By Roohi Mariam Peter

Podcast 6 Oct 2023

Beyond Biotech podcast 66 – treating rare diseases with tRNA

Compared to the smallest mRNA molecule, which is 300 nucleotides long, the largest transfer RNAs (tRNA) is less than a third of the size at 76 nucleotides. Scientists at Alltrna…

October 6, 2023 - 2 minutesmins - By Jim Cornall

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Power your event with partnering to deliver attendee ROI. Learn more!

Download Inpart’s latest report

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inpart, the leading platform for biopharma partnering